Diverse peptide presentation of rhesus macaque major histocompatibility complex class I Mamu-A*02 revealed by two peptide complex structures and insights into immune escape of simian immunodeficiency virus

Journal of Virology

Volumn 85, Issue 14, 2011, Pages 7372-7383

  Liu, Jun ^a,b   Dai, Lianpan ^a   Qi, Jianxun ^a   Gao, Feng ^b,c   Feng, Youjun ^a   Liu, Wenjun ^a   Yan, Jinghua ^a   Gao, George F ^a,d  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c SICHUAN UNIVERSITY   (China)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE GY9; PEPTIDE YY9; PROTEIN MAMU A; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN STRUCTURE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; RHESUS MONKEY; SEQUENCE ALIGNMENT; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES DIFFERENCE; VIRUS MUTANT;

AMINO ACID SEQUENCE; ANIMALS; CRYSTALLIZATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE EVASION; MACACA MULATTA; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 79960403342     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00350-11     Document Type: Article

References (78)

1. Achour, A., et al. 2006. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human β2-microglobulin. J. Mol. Biol. 356:382-396.
2. Adams, P. D., et al. 2002. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58:1948-1954.
3. Bjorkman, P. J., et al. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506-512.
4. Bontrop, R. E., and D. I. Watkins. 2005. MHC polymorphism: AIDS susceptibility in non-human primates. Trends Immunol. 26:227-233.
5. Borrow, P., H. Lewicki, B. H. Hahn, G. M. Shaw, and M. B. Oldstone. 1994. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
6. Brünger, A. T., et al. 1998. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54:905-921.
7. Budde, M. L., et al. 2011. Transcriptionally abundant major histocompatibility complex class I alleles are fundamental to nonhuman primate simian immunodeficiency virus-specific CD8_ T cell responses. J. Virol. 85:3250-3261.
8. Burwitz, B. J., et al. 2011. Simian immunodeficiency virus SIVmac239nef vaccination elicits different Tat28-35SL8-specific CD8+ T-cell clonotypescompared to a DNA prime/adenovirus type 5 boost regimen in rhesus macaques. J. Virol. 85:3683-3689.
9. Cale, E. M., et al. 2011. Epitope-specific CD8+ T lymphocytes cross-recognize mutant simian immunodeficiency virus (SIV) sequences but fail to contain very early evolution and eventual fixation of epitope escape mutations during SIV infection. J. Virol. 85:3746-3757.
10. Carrington, M., and R. E. Bontrop. 2002. Effects of MHC class I on HIV/SIV disease in primates. AIDS 16(Suppl. 4):S105-S114.
11. Chen, Y., et al. 2009. Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its non-binding to MHC complexes. J. Mol. Biol. 386:841-853.
12. Chen, Y., Y. Shi, H. Cheng, Y. Q. An, and G. F. Gao. 2009. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands. IUBMB Life 61:579-590.
13. Chu, F., et al. 2007. First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escape. J. Immunol. 178: 944-952.
14. Chu, F., et al. 2005. Complex assembly, crystallization and preliminary X-ray crystallographic studies of rhesus macaque MHC Mamu-A*01 complexed with an immunodominant SIV-Gag nonapeptide. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 61:614-616.
15. Chung, C., et al. 2007. Not all cytokine-producing CD8+ T cells suppress simian immunodeficiency virus replication. J. Virol. 81:1517-1523.
16. Dzuris, J. L., et al. 2000. Conserved MHC class I peptide binding motif between humans and rhesus macaques. J. Immunol. 164:283-291.
17. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60:2126-2132.
18. Feng, Y., et al. 2006. X-ray crystallographic characterization of rhesus macaque MHC Mamu-A*02 complexed with an immunodominant SIVGag nonapeptide. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 62:13-15.
19. Friedrich, T. C., et al. 2004. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat. Med. 10:275-281.
20. Gallo, R. C., and L. Montagnier. 2003. Retrospective: the discovery of HIV as the cause of AIDS. N. Engl. J. Med. 349:2283-2285.
21. Gardner, M. B. 1989. SIV infected rhesus macaques: an AIDS model for immunoprevention and immunotherapy. Adv. Exp. Med. Biol. 251:279-293.
22. Gleimer, M., et al. 2011. Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLAA* 02 have overlapping peptide-binding repertoires. J. Immunol. 186:1575-1588.
23. Goonetilleke, N., et al. 2009. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 206:1253-1272.
24. Gouet, P., X. Robert, and E. Courcelle. 2003. ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Res. 31:3320-3323.
25. Harari, A., et al. 2008. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J. Exp. Med. 205:63-77.
26. Johnson, R. P. 1996. Macaque models for AIDS vaccine development. Curr. Opin. Immunol. 8:554-560.
27. Kaizu, M., et al. 2007. Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes. Immunogenetics 59:693-703.
28. Karim, S. S. A., Q. A. Karim, E. Gouws, and C. Baxter. 2007. Global epidemiology of HIV-AIDS. Infect. Dis. Clin. North Am. 21:1-17.
29. Kilmarx, P. H. 2009. Global epidemiology of HIV. Curr. Opin. HIV AIDS 4:240-246.
30. Koch, M., et al. 2007. Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding. Immunity 27:885-899.
31. Koup, R. A., et al. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
32. Laskowski, R. A., M. W. Macarthur, D. S. Moss, and J. M. Thornton. 1993. Procheck-a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291.
33. Li, L., and M. Bouvier. 2004. Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue. J. Immunol. 172:6175-6184.
34. Li, X., et al. 30 March 2011. Two distinct conformations of a rinderpest virus epitope presented by bovine major histocompatibility complex class I N*01801 (BoLA-A11): a host strategy to present featured peptides. J. Virol. doi:10.1128/JVI.00030-11.
35. Liu, J., et al. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457:87-91.
36. Liu, J., et al. 2010. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J. Infect. Dis. 202:1171-1180.
37. Liu, J., et al. 2010. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein. J. Virol. 84:11849-11857.
38. Liu, J., S. Zhang, S. Tan, B. Zhen, and G. F. Gao. 2011. Revival of the identification of CTL epitopes for immunological diagnosis, therapy and vaccine development. Exp. Biol. Med. doi:10.1258/ebm.2010.010278.
39. Loffredo, J. T., et al. 2007. The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape. J. Virol. 81:2624-2634.
40. Loffredo, J. T., et al. 2004. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition. J. Immunol. 173:5064-5076.
41. Macdonald, I. K., et al. 2010. MHC class I bound to an immunodominant Theileria parva epitope demonstrates unconventional presentation to T cell receptors. PLoS Pathog. 6:e1001149.
42. Maenaka, K., et al. 2000. Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes. J. Immunol. 165:3260-3267.
43. Maness, N. J., et al. 2010. Robust, vaccine-induced CD8+ T lymphocyte response against an out-of-frame epitope. J. Immunol. 184:67-72.
44. Manuel, E. R., et al. 2006. Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses. J. Virol. 80:12032-12040.
45. Matsui, M., C. E. Hioe, and J. A. Frelinger. 1993. Roles of the six peptidebinding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones. Proc. Natl. Acad. Sci. U. S. A. 90:674-678.
46. Messaoudi, I., J. A. Guevara Patino, R. Dyall, J. LeMaoult, and J. Nikolich-Zugich. 2002. Direct link between MHC polymorphism, T cell avidity, and diversity in immune defense. Science 298:1797-1800.
47. Minang, J. T., et al. 2010. Distribution, persistence, and efficacy of adoptively transferred central and effector memory-derived autologous simian immunodeficiency virus-specific CD8+ T cell clones in rhesus macaques during acute infection. J. Immunol. 184:315-326.
48. Mothé, B. R., et al. 2003. Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 77:2736-2740.
49. Mühl, T., M. Krawczak, P. Ten Haaft, G. Hunsmann, and U. Sauermann. 2002. MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 169: 3438-3446.
50. Murshudov, G. N., A. A. Vagin, and E. J. Dodson. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53:240-255.
51. Newberg, M. H., et al. 2006. Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 176:319-328.
52. O'Connor, D. H., et al. 2002. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat. Med. 8:493-499.
53. O'Connor, D. H., et al. 2003. Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses. J. Virol. 77:9029-9040.
54. Otwinoski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
55. Patel, V., et al. 2010. Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization. Vaccine 28:4827-4836.
56. Price, D. A., et al. 2004. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 21:793-803.
57. Purcell, A. W., J. McCluskey, and J. Rossjohn. 2007. More than one reason to rethink the use of peptides in vaccine design. Nat. Rev. Drug Discov. 6:404-414.
58. Reynolds, M. R., et al. 2008. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J. Exp. Med. 205:2537-2550.
59. Robinson, S., et al. 2001. A commonly recognized simian immunodeficiency virus Nef epitope presented to cytotoxic T lymphocytes of Indian-origin rhesus monkeys by the prevalent major histocompatibility complex class I allele Mamu-A*02. J. Virol. 75:10179-10186.
60. Roshorm, Y., et al. 2009. Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101_ patients protected mice against chimaeric ecotropic HIV-1 challenge. Eur. J. Immunol. 39:1831-1840.
61. Sauermann, U. 2001. Making the animal model for AIDS research more precise: the impact of major histocompatibility complex (MHC) genes on pathogenesis and disease progression in SIV-infected monkeys. Curr. Mol. Med. 1:515-522.
62. Sauermann, U., et al. 2008. MHC class I haplotypes associated with survival time in simian immunodeficiency virus (SIV)-infected rhesus macaques. Genes Immun. 9:69-80.
63. 2-microglobulin: interactions with murine MHC I molecules. Mol. Immunol. 35:919-928.
64. + T cells without selection of higher affinity TCR. Nat. Immunol. 2:711-717.
65. Sliz, P., et al. 2001. Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes. J. Immunol. 167:3276-3284.
66. Smith, K. J., et al. 1996. An altered position of the α2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4:203-213.
67. Stewart-Jones, G. B., et al. 2005. Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. J. Immunol. 175:2459-2468.
68. Sun, Y., et al. 2010. Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses. J. Gen. Virol. 91:919-930.
69. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.
70. Turner, S. J., P. C. Doherty, J. McCluskey, and J. Rossjohn. 2006. Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 6:883-894.
71. Turner, S. J., et al. 2005. Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations. Nat. Immunol. 6:382-389.
72. Vogel, T. U., et al. 2002. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence? J. Virol. 76:11623-11636.
73. Vojnov, L., et al. 2010. Effective simian immunodeficiency virus-specific CD8+ T cells lack an easily detectable, shared characteristic. J. Virol. 84: 753-764.
74. Watanabe, N., et al. 1994. A simian immunodeficiency virus envelope V3 cytotoxic T-lymphocyte epitope in rhesus monkeys and its restricting major histocompatibility complex class I molecule Mamu-A*02. J. Virol. 68:6690-6696.
75. Willcox, B. E., et al. 1999. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 10:357-365.
76. Zhang, Z. Q., et al. 2002. Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection. J. Virol. 76:12845-12854.
77. Zinkernagel, R. M., and P. C. Doherty. 1974. Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature 251:547-548.
78. Zong, L., et al. 2009. Rhesus macaque: a tight homodimeric CD8αα. Proteins 75:241-244.